Research Highlights: In a Phase 1, first-in-human trial, a one-time infusion of an investigational CRISPR-Cas9 therapy targeting angiopoietin-like protein 3 (ANGPTL3) was safe and reduced LDL cholesterol by nearly 50% and reduced triglycerides by...
There are a lot more problems in trying to create the infrastructure to enforce sanctioned uses of any readily accessible technology than there is in the use of said tool. The people who want to do the most harm inevitability wind up in the oversight position, while society tends to create enforcement mechanisms at a social, interpersonal level organically already.
There are a lot more problems in trying to create the infrastructure to enforce sanctioned uses of any readily accessible technology than there is in the use of said tool. The people who want to do the most harm inevitability wind up in the oversight position, while society tends to create enforcement mechanisms at a social, interpersonal level organically already.